STING agonist-49-β-D-Glu-benzylalcohol-di (amide-C2) -mal

STING agonist-49-β-D-Glu-benzylalcohol-di (amide-C2) -mal (compound gluc-cSTING linker-payload) is a drug-linker conjugate for ADC. STING agonist-49-β-D-Glu-benzylalcohol-di (amide-C2) -mal can be used for ADC synthesis[1].

Product Specifications

CAS Number

[2803608-01-5]

UNSPSC

12352005

Target

Drug-Linker Conjugates for ADC

Related Pathways

Antibody-drug Conjugate/ADC Related

Field of Research

Cancer

Smiles

O=C(N(C)CCCOC1=CC(C(N)=O)=CC2=C1N(C(NC(C3=CC(C)=NN3CC)=O)=N2)C/C=C/CN4C(NC(C5=CC(C)=NN5CC)=O)=NC6=CC(C(N)=O)=CC(OC)=C64)OCC7=C(NC(CCNC(CCN8C(C=CC8=O)=O)=O)=O)C=C(O[C@H]9[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O9)C=C7

Molecular Formula

C63H72N16O19

Molecular Weight

1357.34

References & Citations

[1]Gruber DR, et al. Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models. Mol Cancer Ther. 2025 Oct 29.